Corporate

Practice

Filters

Royalty Pharma $2.5 billion IPO

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering…

Royalty Pharma $2.5 billion IPO

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering…

Royalty Pharma $2.5 billion IPO

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering…

Royalty Pharma $2.5 billion IPO

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering…

Credicorp $500 million notes offering

Davis Polk advised Credicorp Ltd. in connection with its $500 million offering of 2.750% notes due 2025, which were issued…
Back to top